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Functional expression of a cDNA encoding a human ecto-ATPase
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1 The metabolism of extracellular nucleotides plays an important role in nucleotide signalling
mediated by P2 receptors. The nucleotide sequence encoding a putative human ecto-ATPase named
CD39L1 was reported recently. However, the biological activity of this protein has not been
established.
2 Based on the sequence of CD39L1 we isolated from mRNA from human ECV-304 cells a
sequence encoding a 495 amino acid protein that is identical to CD39L1, with the exception that this
sequence contains a 23 amino acid stretch in the putative extracellular loop that is missing in
CD39L1. Partial sequence of a genomic DNA clone indicates that the CD39L1 gene corresponds to
an alternative spliced form of the human ecto-ATPase.
3 Stable expression of isolated sequence in NIH-3T3 mouse ®broblasts conferred a marked
nucleotide hydrolytic activity consistent with the activity of an ecto-ATPase.
4 The human ecto-ATPase hydrolyzed all naturally occurring nucleoside triphosphates in a Ca2+-
or Mg2+-dependent manner. Nucleoside diphosphates were hydrolyzed at a rate approximately 5%
of that of the corresponding triphosphates. The apparent Km and Vmax values were: 394+62 mM and
107+7 nmol Pi min71 106 cells71 for the hydrolysis of ATP, and 102+33 mM and 4+0.4 nmol Pi -
min71 106 cells71 for the hydrolysis of ADP, respectively.
5 In conclusion, we report here the cloning and functional expression of a human ecto-ATPase.
The study of the biochemical properties and the regulatory mechanisms of ecto-ATPases of de®ned
sequence will be valuable in the de®nition of their role in nucleotide signalling.
Keywords: ecto-ATPase; CD39; CD39L1; nucleotide hydrolysis; ecto-nucleotidases; extracellular nucleotides; NIH3T3 cells;
alternative splicing
Abbreviations: ACR, apyrase conserved regions; ADP, adenosine 5'-diphosphate; AMP, adenosine 5'-monophosphate; ATCC,
American type culture collection; ATP, adenosine 5'-triphosphate; CTP, cytidine 5'-triphosphate; DSM, German
cell culture collection; GTP, guanosine 5'-triphosphate; NDP's, nucleoside 5'-diphosphate; NTP's, nucleoside 5'-
triphosphates; PCR, polymerase chain reaction; Pi, inorganic phosphate; UTP, uridine 5'-triphosphate
Introduction
Extracellular ATP and other nucleotides modulate important
physiological responses through interaction with G protein-
coupled receptors and ligand-gated ion channel receptors
known as P2Y and P2X receptors, respectively (Dubyak & El-
Moatassim, 1993; Abbracchio & Burnstock, 1994; Harden et
al., 1995). Nucleotide-promoted signalling is abrogated by the
rapid degradation and/or interconversion of extracellular
nucleotides by ecto-nucleotidases. For example, ATP is a
potent agonist at P2Y2 receptors, but its hydrolysis by ecto-
enzymes produces the corresponding nucleotide di- and
monophosphate and the nucleoside adenosine; all of these
metabolic products are inactive at P2Y2 receptors. On the
other hand, ADP is more potent than ATP at P2Y1 receptors
and adenosine is the cognate agonist of A1, A2 and A3
adenosine receptors. Although the physiological signi®cance of
ecto-nucleotidases is not fully understood, their ubiquitous
distribution (Plesner, 1995) and frequent co-localization with
P2 receptors indicate that their primary function is associated
with nucleotide signalling. Recent reports suggest that ecto-
nucleotidases have additional roles including cell adhesion,
vesicular transport, and purine recycling (Plesner, 1995;
Zimmermann, 1996b; Strobel & Rosenberg, 1993; Kittel &
Bacsy, 1994).
Ecto-nucleotidases comprise a large group of extracellular
enzymes expressing dierent nucleotide selectivities and
biochemical properties. Thus, ecto-ATPase hydrolyzes nucleo-
side 5'-triphosphates (NTP's) into nucleoside 5'-diphosphates
(NDP's) and inorganic phosphate (Pi); ecto-ATP diphos-
phohydrolase, also known as ATPDase, apyrase or CD39,
hydrolyzes NTP's and NDP's at approximately the same rate,
producing the corresponding nucleoside monophosphates.
Other enzymes involved in extracellular nucleotide hydrolysis
or interconversion include phosphodiesterases, adenylate
kinases, nucleoside diphosphate kinase (NDPK), ecto-5'
nucleotidase, nucleotide pyrophosphatases, dinucleoside poly-
phosphate hydrolases, etc. (Zimmermann, 1996a).
Ecto-ATPase is an integral membrane protein that requires
millimolar concentrations of divalent cations (Ca2+ or Mg2+)
and hydrolyzes all naturally occurring nucleoside 5'-triphos-
phates. The activity of ecto-ATPase against nucleoside
diphosphates is only 3 ± 5% of the activity observed against
nucleoside triphosphates (Kegel et al., 1997). Ecto-ATPase
activity is not inhibited by the commonly used inhibitors of
intracellular ATPases (Plesner, 1995; Zimmermann, 1996a).
Genes encoding ecto-ATPases have been cloned from chicken
gizzard (Kirley, 1997), rat brain (Kegel et al., 1997) and mouse
hepatoma cells (Gao et al., 1998). The predicted structure of
the proteins encoded by these genes suggests that the ecto-
ATPase contains two transmembrane domains with very short
amino- and carboxy-termini facing the intracellular space, and
a large extracellular loop containing several potential N-
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glycosylation sites. This structure is remarkably similar to that
predicted for ATP diphosphohydrolase (Kirley, 1997; Kegel et
al., 1997; Gao et al., 1998; Zimmermann et al., 1998). A human
ecto-ATPase sequence named CD39L1 was reported recently
by Chadwick & Frischauf (1997). This sequence exhibits a high
degree of homology with previously described ecto-ATPases
(57 ± 83%) and with the ecto-ATP diphosphohydrolases from
dierent species (40 ± 50%), and sequence comparisons
indicated CD39L1 was most prominently dierent in a 23-
amino acid sequence not present in the last third of the
putative extracellular loop of the protein. Biological activity of
the cloned CD39L1 has not been reported.
In this study we describe the cloning and functional
expression of a DNA sequence obtained from human ECV-
304 cells. This sequence contains an open reading frame of
1485 base pairs and has homology with the ecto-ATPases
previously reported (chicken gizzard, rat brain and mouse
hepatoma cells). Moreover, the ECV-304 cell DNA corre-
sponds to the sequence reported by Chadwick & Frischauf
(1997), except that the DNA isolated here encodes a 23 amino
acid sequence that was not present in the previously reported
sequence. Stable expression of this gene in NIH-3T3 mouse
®broblast cells confers a marked nucleotide hydrolytic activity
consistent with the activity of an ecto-ATPase.
Methods
Materials
ATP was from Research Biochemicals Inc. (Natick, MA,
U.S.A.). UTP, CTP, GTP, XTP, ITP, ADP, UDP, AMP,
dATP, dUTP, dCTP, dGTP, adenosine and hygromycin B
were from Boehringer Mannheim (Mannheim, Germany).
HPLC-grade water and acetonitrile were purchased from
Fisher Scienti®c (Pittsburgh PA, U.S.A.). KH2PO4 standard
solution was from Sigma Chemical Co. (St. Louis, MO,
U.S.A.). All tissue culture reagents were from the Lineberger
Comprehensive Cancer Center tissue culture facility at the
University of North Carolina. Sources of other products were
previously reported (Boyer et al., 1997)
Cell culture
The murine packaging cell line PA317 was grown in DMEM
containing 4.5 g liter71 of glucose, 10% foetal calf serum, and
no antibiotics. ECV304 cells (ATCC CRL-1998) were grown in
199 medium supplemented with 10% foetal calf serum,
50 U ml71 penicillin and 50 mg ml71 streptomycin. NIH-3T3
cells stably expressing the ecto-ATPase and vector control cells
were grown in DMEM containing 4.5 g liter71 of glucose,
10% bovine calf serum, and 400 mg ml71 hygromycin B. All
cells were maintained at 378C in a humidi®ed atmosphere of
5% CO2, 95% air except where indicated.
Human ECV-304 cells were originally introduced to the cell
banks as an endothelial cell line. However, recently the origin
of this cell line has been questioned, and there is unpublished
evidence that ECV-304 cells derived from the human bladder
T24 cell line. For updated information on the origin of ECV-
304 cells contact the American type culture collection (ATCC)
or the German cell culture collection (DSM).
Isolation of the human ecto-ATPase cDNA
The cDNA encoding the human ecto-ATPase was obtained by
RT±PCR ampli®cation of mRNA from human ECV304 cells.
Messenger RNA was isolated from ECV304 cultures using the
Fast Track 2.0 Kit (Invitrogen). First-strand cDNA synthesis
was performed using 0.1 mg of mRNA as template and
oligo(dT) as primer for the reverse transcriptase (RT±PCR
Kit, Stratagene). The PCR reaction (100 ml) was developed in
the presence of 5.0 Units of Pfu DNA Polymerase (Stratagene)
and contained 5 ml of the cDNA obtained in the RT reaction
as the template and 0.4 mM of each of the ampli®cation
primers. The PCR primers were designed to amplify the
complete coding sequence of the putative human ecto-ATPase
CD39L1 (GenBank accession number U91510), and corre-
sponded to the 5'- and 3'-untranslated regions. To facilitate the
cloning into the expression vector, the primers were designed
to contain restriction sites for EcoRI and XhoI in the 5' and 3'
ends, respectively. Sense primer, 5'-GAG AGA ATT CCC
GCC CAT GGC CGG GAA GGT GCG GTC A-3', antisense
primer, 5'-GAG ACT CGA GAG TAC GGG GTG GGG
ATA CAG GGG TTG G-3'. The PCR protocol consisted of
35 cycles of ampli®cation structured in the following steps: 45 s
at 948C, 1 min at 608C, and 3 min at 728C, and included an
initial 4.5 min denaturation period at 948C and a ®nal 10 min
extension at 728C in a Perkin Elmer DNA thermal cycler
model 480. The ampli®ed PCR product was puri®ed
(QIAquick PCR Puri®cation Kit, QIAGEN), digested with
EcoRI and XhoI, and ligated into the retroviral expression
vector pLXPIH, previously digested with the same restriction
enzymes. The resultant DNA construct was ampli®ed and
puri®ed (QIAGEN). DNA was sequenced at the UNC-CH
Automated DNA Sequencing Facility on a model 377 DNA
sequencer (Perkin Elmer, Applied Biosystems Division) using
the ABI PRISMTM Dye Terminator Cycle Sequencing Ready
Reaction Kit with AmpliTaq DNA Polymerase (Perkin Elmer,
Applied Biosystems Division). The PCR ampli®cation product
was absolutely dependent on the presence of reverse
transcriptase, indicating that the ampli®ed sequence originated
from mRNA. The ampli®ed sequence contained an open
reading frame encoding a predicted 495 amino acid protein.
Stable expression of the human ecto-ATPase in
NIH-3T3 mouse ®broblast cells
Retrovirus harboring the ecto-ATPase was produced as
previously described by Comstock et al. (1997). Brie¯y, the
pLXPIH vector harbouring the human ecto-ATPase cDNA
was transfected into the murine packaging cell line PA317 by
the calcium phosphate transfection method. Transfected cells
were incubated for 48 h at 328C in the presence of 5 mM
butyrate and the cell supernatant containing packaged
retroviruses was collected, ®ltered, and used to infect wild
type NIH-3T3 cells. Infection was carried out for 2 h in the
presence of 8 mg ml71 polybrene. After 48 h, infected NIH-
3T3 cells were selected for hygromycin B resistance by
supplementing the growth medium with 400 mg ml71 hygro-
mycin B. Clonal cell lines that stably express the human ecto-
ATPase were obtained. NIH-3T3 cells expressing the empty
pLXPIH vector were produced in the same manner and used
as controls in further experiments.
Assay of ecto-ATPase activity
NIH-3T3 cells stably expressing the vector control or the ecto-
ATPase were seeded in 48-well plates at 56104 cells per well
and assayed after cells reached con¯uence, usually 2 ± 3 days
after plating. Brie¯y, the cells were washed once with 1 ml of
phosphate-free saline solution (mM): NaCl 125, KCl 5.2,
HEPES 20, (pH 7.4), CaCl2 2, MgCl2 1.2 and D-glucose 5, and
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incubated at 378C in 250 ml ®nal volume of the same medium
containing the indicated concentrations of nucleotide. The
incubation was terminated by transferring the cell-free super-
natants of each well to a new plate containing 50 ml per well of
60 mM EDTA at 48C. The cell supernatants were microwaved
for 20 s to inactivate any possible released nucleotidase
activity. Nucleotide hydrolysis in the cell supernatants was
assayed by HPLC or by the release of inorganic phosphate.
HPLC measurement of nucleotide hydrolysis
Cell supernatants prepared as described above were ®ltered
and nucleotide content determined by reverse phase HPLC on
an analytical C18 column (Dinamax C-18, 25064.6 mm, 60 AÊ ,
Rainin). Separation of nucleotides and nucleosides was
achieved using a paired-ion chromatography protocol with a
linear gradient of acetonitrile (5 ± 30%) in 10 mM KH2PO4,
pH 7.5, and 2 mM tetrabutylammonium hydrogen sulphate,
over 20 min at a ¯ow rate of 2 ml min71. Absorbance at
254 nm was monitored on-line with a Waters UV detector
model 490.
Phosphate assay
Inorganic phosphate was determined colorimetrically using a
modi®cation of the malachite green-based assay described by
Lanzetta et al. (1979). Usually, 30 ml of cell supernatants were
combined with 100 ml of malachite green reagent, mixed and
the absorbance at 595 nm was determined in a plate reader.
The inorganic phosphate content in the cell supernatant was
determined by comparison against a standard curve con-
structed with known amounts of phosphate.
Results
Isolation and sequencing of a human ecto-ATPase cDNA
Chadwick & Frischauf (1997) recently reported the cloning
and chromosomal localization of a human gene (named
CD39L1) that exhibits high homology to chicken muscle
ecto-ATPase and to human CD39. Introduction of a gap of 23
amino acids in the CD39L1 sequence was necessary to obtain
optimal alignment of the predicted amino acid sequences of
these proteins. The reported human gene was not expressed,
and therefore, no examination of biological activity was
provided. As such, we have isolated a human ecto-ATPase
sequence with the goal of studying its biological properties.
Preliminary results indicated that ECV304 cells express a
marked nucleotide hydrolytic activity consistent with that of
an ecto-ATPase (data not shown). Therefore, this cell line was
used as a source for isolation of the ecto-ATPase gene. Using
RT±PCR and primers corresponding to the 5'- and 3'-
untranslated regions of CD39L1, we isolated a cDNA from
ECV304 cells following the procedure detailed in Methods.
The isolated sequence contained an open reading frame of
1485 bp encoding a 495 amino acid protein (Figure 1). This
sequence corresponded to that reported by Chadwick &
Frischauf (1997), with the exception that the open reading
frame in the sequence reported here is 69 bp longer resulting in
a predicted protein containing an additional 23 amino acids.
Importantly, the extra sequence found in our clone
corresponded exactly to the gap introduced in CD39L1 to
obtain an optimal alignment with related proteins. This
observation suggests that the CD39L1 clone reported by
Chadwick & Frischauf (1997) likely is an alternatively spliced
product. Figure 2 shows the alignment of our sequence with
CD39L1, and human CD39.
The analysis of the amino acid sequence of the human ecto-
ATPase reported here (see activity data below), predicts two
potential transmembrane domains at the extremes of the
protein (8 and 12 amino acids from the amino- and carboxy-
termini, respectively), suggesting a topology of a large
extracellular loop with two short amino and carboxy termini
facing the intracellular space. Hydrophobicity and surface
probability analysis also predict an hydrophobic region (amino
acids 340 ± 375) of the putative extracellular loop that could
potentially form a reentry loop, as suggested by Kegel et al.
(1997) for the rat ecto-ATPase and ecto-ATP diphosphohy-
Figure 1 DNA sequence and predicted protein sequence of the
human ecto-ATPase. Underlined with solid lines are the two putative
transmembrane domains. &, Potential N-glycosylation sites;
*, potential protein kinase A phosphorylation sites; ~, potential
protein kinase C phosphorylation sites. Boxed sequences correspond
to apyrase conserved regions. This sequence has been submitted to
the GeneBank database with accession number AF144748.
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drolase. A consensus site for protein kinase C phosphorylation
(Ser 488) and one for protein kinase A (Ser 493) are found in
the short intracellular C-terminal domain. Six potential N-
glycosylation sites occur in the predicted large extracellular
loop. Other potential phosphorylation sites for cyclic AMP
dependent protein kinase (residues 161, 196, 237, 271 and 459),
and a second protein kinase C phosphorylation site (Ser 296)
are found in the predicted extracellular loop. The human ecto-
ATPase (Figure 1) and the alternatively spliced form, CD39L1,
contain the ®ve `apyrase conserved regions' (ACR) present in
other ecto-ATPases and in ATP diphosphohydrolases (Handa
& Guidotti, 1996; Vasconcelos et al. 1996). The amino acid
identity of the human ecto-ATPase with ecto-ATPases from
other species ranges from 57% identity to chicken to 83%
identity to rat. The identity to human ecto-ATP dipho-
sphohydrolase is 41% (Figure 2).
Expression of human ecto-ATPase in mammalian cells
Experiments were conducted to identify cell lines suitable for
the expression of the ecto-ATPase, and several cells that
express no or low levels of endogenous ecto-nucleotidase
Figure 2 Alignment of deduced amino acid sequences of the human ecto-ATPase, CD39L1, and human CD39. Shaded areas
indicate amino acid identity to the human ecto-ATPase described here. Gaps (7) were introduced to improve alignment. GeneBank
accession numbers are: U91510 for CD39L1 and S73813 or U87967 for CD39.
Figure 3 Rate of hydrolysis of ATP, ADP and AMP by NIH-3T3 cells expressing the human ecto-ATPase. NIH-3T3 cells
expressing the empty pLXPIH vector (a) or the vector containing the ecto-ATPase gene (b) were incubated at 378C with 100 mM
ATP, ADP or AMP as described in Methods. At indicated times the reaction was stopped and the cell-free supernatant was
removed from the cells. Nucleotide hydrolysis was estimated as the release of inorganic phosphate. Data shown are the
mean+s.e.mean of triplicate assays from a representative experiment repeated at least ®ve times using con¯uent monolayers of cells
seeded in 48-well culture plates.
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activity were identi®ed. For example, essentially no nucleotide
hydrolytic activity was found in NIH-3T3 mouse ®broblasts
during incubation with 100 mM ATP, ADP and AMP (data not
shown). This cell line was chosen for expression of the human
ecto-ATPase.
The retroviral vector pLXPIH alone or vector engineered
to contain the human ecto-ATPase cDNA were transfected
into the viral packaging cell line PA317, and retroviruses
from these constructs were used to infect NIH-3T3 murine
®broblast cells. Clonal cell lines derived from populations of
infected cells were isolated and tested for expression of ecto-
nucleotidase activity.
Stable expression of the human ecto-ATPase in NIH-3T3
cells resulted in a high hydrolytic activity against extra-
cellular ATP (Figure 3), whereas under the same experi-
mental conditions, ADP was hydrolyzed at much lower rate
(Figure 3b). In contrast, no nucleotide hydrolytic activity
was observed in cells infected with retrovirus containing
empty pLXPIH vector (Figure 3a). AMP was not
hydrolyzed by the ecto-ATPase (Figure 3b). These results
indicate that the cDNA sequence isolated and expressed in
this study corresponds to a functional human ecto-ATPase,
and that CD39L1 originally reported by Chadwick &
Frischauf (1997) corresponded to an alternative spliced form
of the human ecto-ATPase.
To further investigate the biochemical characteristics of the
ecto-ATPase, we determined the substrate speci®city of the
enzyme for all the naturally occurring nucleoside triphosphates
UTP, ATP, CTP, GTP, dATP, dUTP, dCTP, dGTP, ITP and
XTP. NIH-3T3 cells stably expressing the ecto-ATPase
hydrolyzed in a time- and Ca2+ or Mg2+ concentration-
dependent manner all the natural nucleoside triphosphates
with approximately the same rate. The nucleoside diphosphate
forms (ADP and UDP) were hydrolyzed at a rate of
approximately 5 ± 10% of that of the corresponding tripho-
sphates (Table 1).
To obtain the apparent kinetic parameters for the
hydrolysis of nucleoside triphosphates and nucleoside
diphosphates by the human ecto-ATPase, we measured
the initial rates of hydrolysis of ATP and ADP at
concentrations of nucleotide ranging from 1 mM to 1 mM
(Figure 4). Km and Vmax values for the human ecto-
ATPase were obtained from the substrate concentration-
activity data, according to the Michaelis-Menten equation
(Segel, 1993). These values were of 394+62 mM and
107+7 nmol Pi min71 106 cells71 for ATP, and 102+33 mM
and 4+0.4 nmol Pi min71 106 cells71 for ADP, respectively
(n=5 experiments).
Discussion
A cDNA encoding an ecto-ATPase was isolated from human
ECV-304 cells and its predicted 495 amino acid sequence was
found identical in length, and highly homologous to ecto-
ATPases previously reported from rat brain (Kegel et al.,
1997), mouse hepatoma cells (Gao et al., 1998), and chicken
muscle (Kirley et al., 1997). The human cDNA sequence
reported recently by Chadwick & Frischauf (1997), known as
CD39L1, corresponds to the same gene reported here, except
that our sequence is 23 amino acids longer. The alignment of
the amino acid sequences, the predicted protein sizes, and the
structures of ecto-ATPases from other species suggested that
the sequence reported by Chadwick & Frischauf (1997)
corresponded to an alternative splice of the ecto-ATPase gene.
Indeed, we have partially sequenced a human genomic DNA
clone and localized the sequence encoding the 23 amino acids
missing in CD39L1 as the 5' end of an exonic sequence (data
not shown). The intron-exon boundaries for this 69 bp
fragment conform to the splice donor and acceptor consensus
sequences (data not shown). Further evidence that this 23
amino acid sequence is an integral part of the coding sequence
of the human ecto-ATPase comes from the identity of the
predicted sequence with corresponding regions in ecto-
ATPases from other species (83% identity to rat and mouse
ecto-ATPases, and 57% to chicken ecto-ATPase). Addition of
the 69-bp fragment to the coding sequence of CD39L1 results
in a predicted 495 amino acid protein identical in size to the
human ecto-ATPase reported here and ecto-ATPases from
other species.
The predicted structure of the human ecto-ATPase is
similar to that suggested for the ecto-ATP diphosphohydrolase
(CD39), and for the rat, mouse, and chicken ecto-ATPases.
That is, the existence of two transmembrane domains at the N-
and C-terminus result in a large extracellular loop and in two
short 8- and 12-amino acid intracellular domains at the N- and
C-terminus, respectively. A high degree of structural conserva-
Table 1 Substrate speci®city of the human ecto-ATPase
Substrate
(100 mM)
Nucleotide-hydrolysis
(% of ATP)
ATP
ADP
UTP
UDP
CTP
GTP
ITP
XTP
100
10.6+2.4
64.1+2.6
5.8+2.9
69.0+6.2
92.9+11.2
68.2+2.9
121.4+8.8
Rates of phosphate release were expressed as the per cent
relative to the rate of ATP hydrolysis, that was of
22.2+6.3 nmol Pi min71 106 cells71 at 378C. Data are
mean+s.e.mean of three experiments each in quintuplicate.
Figure 4 Substrate dependence for the hydrolysis of ATP and ADP
by the human ecto-ATPase. NIH-3T3 cells stably expressing the ecto-
ATPase were incubated in the presence of the indicated concentra-
tions of ATP and ADP for 3 min. The rates of hydrolysis were
measured as the release of inorganic phosphate and expressed as
nmol Pi min71 106 cells71 and were obtained from incubations in
which less than 10% of the substrate was hydrolyzed. The data
shown are the mean+s.d.mean from ®ve experiments performed with
triplicate samples.
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tion is observed among ecto-ATPases and ecto-ATP diphos-
phohydrolases. For instance, Handa & Guidotti (1996) and
Vasconcelos et al. (1996) identi®ed ®ve well-conserved regions
(`apyrase conserved regions') in the sequence of potato
apyrase, human and mouse CD39, and other NTPases from
plants, yeast, and protozoans. The core of these non-
contiguous conserved domains also are present in the human
ecto-ATPase, where as previously predicted, they likely play an
important role in the catalytic site of these proteins. All ten
cysteine residues present in the predicted extracellular loop of
the human ecto-ATPase are conserved in chick, mouse, and rat
ecto-ATPases and in mouse and human ecto-ATP diphos-
phohydrolases. These residues might be involved in the
formation of intra-loop disulphide bonds, and in the formation
of multi-subunit complexes as has been suggested by Stout &
Kirley (1996). All members of the ecto-ATPase and ecto-ATP
diphosphohydrolase families are predicted to be highly
glycosylated. The human ecto-ATPase contains six potential
N-glycosylation sites in the predicted extracellular loop, two of
them (Asn 64 and Asn 443) are conserved among human, rat,
mouse, and chicken ecto-ATPases and in the human ecto-ATP
diphosphohydrolase.
Essentially nothing is known about the regulatory mechan-
isms of ecto-nucleotidases. Interestingly, human, rat, and
mouse ecto-ATPases contain potential protein kinase A
phosphorylation sites in the N-terminal (Ser 7) and C-terminal
(Ser 493) intracellular domains. Additionally, the human and
chick ecto-ATPases express another potential protein kinase C
phosphorylation site (Ser 488) in the C-terminus (Figure 1).
The presence of these sites suggest the possibility for the
existence of a regulatory mechanism of enzyme activity by
phosphorylation by intracellular protein kinases A and C, and
for the cross talk between extracellular nucleotide metabolism
and other intracellular signaling mechanisms. Since only
approximately 4% of the ecto-ATPase is in the intracellular
space (8 and 12 amino acids in the N- and C-terminus,
respectively), it is possible that complex regulatory mechan-
isms could occur in the large extracellular loop of the protein.
The existence of ecto-protein kinases, such as protein kinase C,
casein kinase II, and cyclic AMP -dependent protein kinase
(Chen et al., 1996; Walter et al., 1996) and the extracellular
location of conserved potential phosphorylation sites for these
kinases in ecto-ATPases, open the possibility of extracellular
regulation of the catalytic activity of these proteins. However,
no evidence for such regulation has been reported.
Stable expression of the human ECV-304 cell clone in NIH-
3T3 cells conferred a marked Ca2+- or Mg2+-dependent
nucleoside triphosphate-selective hydrolytic activity associated
with the extracellular face of the plasma membrane of these
cells. Therefore, the data presented here indicate that the
cDNA isolated from ECV-304 cells corresponds to a
functional ecto-ATPase (Figures 3 and 4). It will be important
to determine if CD39L1, the alternatively spliced variant
reported by Chadwick & Frischauf (1997), encodes a
functional protein, and in that case, to compare its biochemical
properties with those of the protein reported here.
ATP levels in resting cells are the result of multiple complex
processes including nucleotide release, breakdown, inter-
conversion, and uptake. Extracellular levels of ATP in resting
cultured cells are in the low nanomolar range, and these levels
can increase signi®cantly in response to a variety of factors,
such as mechanical stimulation, release of nucleotide contain-
ing granules, or by cell lysis (Lazarowski et al., 1997). The
apparent Km value of the human ecto-ATPase for ATP
(394+62 mM) was signi®cantly higher than the values reported
for puri®ed preparations of other ecto-nucleotidases. However,
under some physiological circumstances, e.g. platelet activa-
tion, vascular endothelial cells are locally exposed to
millimolar levels of nucleotides, and in this context the
apparent Km value for ATP as substrate is in a physiologically
relevant range. Two other issues should be considered. The
nucleotide concentrations reported here are those of the bulk
phase, and these concentrations could be signi®cantly dierent
than concentrations at the membrane surface. Similarly, the
concentrations of ATP typically measured upon release from
cells also are determined in the bulk phase, and functional data
indicate that much higher concentrations occur at the level of
the plasma membrane (Slakey et al., 1990; Beigi et al., 1999).
Thus, the assessment of relevant concentration of substrate is
very dierent when the activity of the enzyme is measured in
situ as an ecto-enzyme than with puri®ed enzyme or membrane
preparations in solution. More controlled approaches to
address these issues will be necessary for accurate kinetic
analysis of ecto-ATPases in intact cell preparations.
In conclusion, we report here the isolation of the cDNA and
for the ®rst time the functional expression of a human ecto-
ATPase. The study of the biochemical properties and the
regulatory mechanisms of ecto-ATPases will be valuable in the
de®nition of their role in nucleotide signaling and in other
physiological functions.
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